Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice.
Saved in:
| Title: | Correction: Efficacy of afatinib, an irreversible ErbB family blocker, in the treatment of intracerebral metastases of non-small cell lung cancer in mice. |
|---|---|
| Authors: | Zhang SR; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China., Zhu LC; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China., Jiang YP; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Zhang J; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Xu RJ; Department of Pathology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China., Xu YS; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China., Xia B; Department of Oncology, Hangzhou Cancer Hospital, Hangzhou, 310006, China. xb0918@hotmail.com., Ma SL; Hangzhou Translational Medicine Research Center, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Hangzhou Translational Medicine Research Center, Affiliated Hangzhou First People's Hospital of Zhejiang Chinese Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn.; Department of Oncology, Hangzhou First People's Hospital, Nanjing Medical University, Hangzhou, 310006, China. mashenglin@medmail.com.cn. |
| Source: | Acta pharmacologica Sinica [Acta Pharmacol Sin] 2025 Aug; Vol. 46 (8), pp. 2336. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 100956087 Publication Model: Print Cited Medium: Internet ISSN: 1745-7254 (Electronic) Linking ISSN: 16714083 NLM ISO Abbreviation: Acta Pharmacol Sin Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
